Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bio Key International (BKYI) Cash from Operations (2016 - 2025)

Bio Key International (BKYI) has disclosed Cash from Operations for 16 consecutive years, with 1122764.0 as the latest value for Q3 2025.

Quarterly Cash from Operations rose 12.01% to 1122764.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 3352652.0 through Sep 2025, up 14.71% year-over-year, with the annual reading at 2914072.0 for FY2024, 23.18% up from the prior year.
Cash from Operations hit 1122764.0 in Q3 2025 for Bio Key International, down from 880012.0 in the prior quarter.
In the past five years, Cash from Operations ranged from a high of 297084.0 in Q1 2024 to a low of 3198559.0 in Q1 2021.
Historically, Cash from Operations has averaged 1302793.58 across 5 years, with a median of 1420617.0 in 2024.
Biggest YoY gain for Cash from Operations was 115.4% in 2024; the steepest drop was 753.83% in 2024.
Year by year, Cash from Operations stood at 1870306.0 in 2021, then dropped by 1.62% to 1900631.0 in 2022, then rose by 19.42% to 1531534.0 in 2023, then skyrocketed by 66.4% to 514564.0 in 2024, then crashed by 118.2% to 1122764.0 in 2025.
Business Quant data shows Cash from Operations for BKYI at 1122764.0 in Q3 2025, 880012.0 in Q2 2025, and 835312.0 in Q1 2025.